Key result
Patients with chronic kidney disease face high cardiovascular mortality, yet evidence for optimal diagnostic and treatment strategies remains limited due to their exclusion from major clinical trials.
This review highlights the critical gap in evidence for diagnosing and managing cardiovascular disease in patients with chronic kidney disease, primarily due to their frequent exclusion from major clinical trials.
No takes yet. Share an insight, caveat, or question.
Highlights rising CKD burden amid multiple risk factors; leaves open optimal prevention strategies pending prospective data.
Subbiah et al. (2016) conducted a review in Chronic kidney disease and cardiovascular disease. Patients with chronic kidney disease face high cardiovascular mortality, yet evidence for optimal diagnostic and treatment strategies remains limited due to their exclusion from major clinical trials.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: